You are here: Home » News-CM » Companies » Results
Business Standard

Strides Pharma Science reports consolidated net loss of Rs 203.93 crore in the March 2020 quarter

Topics
Business Finance

Capital Market 

Sales rise 0.40% to Rs 618.64 crore

Net loss of Strides Pharma Science reported to Rs 203.93 crore in the quarter ended March 2020 as against net profit of Rs 47.51 crore during the previous quarter ended March 2019. Sales rose 0.40% to Rs 618.64 crore in the quarter ended March 2020 as against Rs 616.18 crore during the previous quarter ended March 2019.

For the full year,net profit declined 88.79% to Rs 36.38 crore in the year ended March 2020 as against Rs 324.61 crore during the previous year ended March 2019. Sales rose 26.33% to Rs 2751.97 crore in the year ended March 2020 as against Rs 2178.37 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear EndedMar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.Sales618.64616.18 0 2751.972178.37 26 OPM %3.279.35 -14.399.03 - PBDT-1.6050.86 PL 293.29398.78 -26 PBT-46.9421.21 PL 119.59281.39 -58 NP-203.9347.51 PL 36.38324.61 -89

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, May 21 2020. 08:01 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU